Canada House Wellness Group Inc

Canada House Wellness Group has defined its position in the Canadian Cannabis industry as an organization focused upon the delivery of evidence-based cannabinoid therapy. The first phase, accumulating patients and providing medical care, has evolved significantly. Canada House Clinics, Knalysis Technologies (developers of our health outcomes analytics platform) and Abba Medix (our cannabis production facility awaiting license approval) have been integrated into the organization to provide the full continuum of care under Canada House Wellness Group. Our software platform enables us to deliver evidence-based cannabinoid therapy to our patients through our clinics, with Abba Medix supplying the strains of cannabis to our patients that our software platform has identified as most efficacious for treating our patients’ conditions.